Discover how Ergomed delivered two Phase III Clinical Trials for Moderate and Severe Postpartum Depression (PPD) in record time.
With the goal of evaluating an intravenous neurosteroid’s efficacy and safety, Ergomed managed rapid patient recruitment and streamlined data reporting to meet ambitious timelines for a fast-tracked FDA process.
Learn how Ergomed’s strategic approach, from awareness campaigns to continuous site support, secured over 220 patients and yielded positive results in under three years. Download the full case study to see how Ergomed empowers biotech and pharma companies to bring innovative treatments to market faster.
